Cell surface glycoconjugate expression of endothelial cells in canine cutaneous hemangiomas and hemangiosarcomas was compared to normal cutaneous endothelial cells using eight different lectins (with and without neuraminidase pretreatment) in an indirect immunoperoxidase technique. Direct comparison of lectin binding pattern of neoplastic endothelial cells with adjacent normal endothelial cells revealed minor changes in the binding intensity of several lectins (enhanced: Wheat germ agglutinin [WGA]; reduced: Griffonia simplicfolia-I [GS-I], Ricinus communis agglutinin-I [RCA-I], Soybean agglutinin after neuraminidase pretreatment [Neu-SBA], and Wheat germ agglutinin after neuraminidase treatment [Neu-WGA]). Neoplastic endothelial cells in some tumors exhibited varying binding of Ulex europaeus agglutinin-I (UEA-I; not binding to normal canine endothelial cells) and no Soybean agglutinin (SBA) binding (variably binding to normal endothelial cells in small cutaneous vessels). Lectin binding of neoplastic cells was rather heterogenous within one tumor compared to the uniform binding pattern of normal endothelial cells. These lectin binding studies demonstrate the phenotypic heterogeneity of neoplastic endothelial cells, indicating changes of cell surface glycosylation during neoplastic transformation.
Lectin histochemistry has been used widely to characterize the glycoconjugate expression of certain cell population^.^ Several studies describe the normal glycoconjugate expression of endothelial cells in vivo5J8, 22 as well as in ~i t r o .~,~ More recently, lectin binding studies have been applied to demonstrate biochemical cell surface alterations during physiological processes, such as embryonic differentiati~n'~ and cell m a t u r a t i~n ,~~ as well as pathologic conditions such as inflammation, I storage diseases,2 metaplastic alterations,21 and neoplastic tran~formation.~~~~,~~,~~ A number of cell surface markers have been used to characterize human vascular neoplasm^.'^,^^ These studies showed that the lectin Ulex europaeus I, which binds to normal human endothelial cells but not to animal endothelia, is the most reliable marker for human vascular derived n e~p l a s m s .~J~J ' ,~~J~ Other lectins, which might detect phenotypic cell surface alterations during neoplastic transformation, have not been studied extensively in vascular tumors.
Both hemangiomas and hemangiosarcomas are common in dogs. 25 Hemangiomas are most frequently found at cutaneous sites, while hemangiosarcomas may be found at any site of the body including cutaneous locations. The objective of this study was to apply lectin histochemistry to cutaneous canine hemangiomas and hemangiosarcomas to compare the lectin binding pattern of neoplastic endothelial cells with that of their normal progenitor cells. This application used lectins as highly specific probes to detect phenotypic changes of endothelial cells during neoplastic transformation.
Materials and Methods
Formalin-fixed, paraffin-embedded blocks from ten cases of hemangiomas and ten cases of hemangiosarcomas were retrieved from the surgical pathology service archives of the New York State College of Veterinary Medicine, Cornell University (Ithaca, NY). Lectin binding patterns of endothelial cells are known to vary in different organs. 22 The skin is often the primary location of vascular tumors in dogs.25 Consequently, only cutaneous vascular tumors were selected for the purpose of this study. All tumors used in this study tested positively for the expression of factor VIII related antigen. 25 Besides these criteria, selection of tissues was made randomly. Tissue specimens were from dogs of ten different breeds ranging in age from 5 to 13 years.
Lectin binding pattern of endothelial cells was determined with an indirect immunoperoxidase technique. Serial sections (3 pm) were deparaffinized in xylene, and endogenous peroxidase was blocked by incubation in 0.3% H202 in methanol for 30 minutes. Sections were hydrated through graded alcohols, washed with 0.01 M phosphate buffered 0.15 M saline (PBS), containing Ca++ and Mg++, and incubated with 10% rabbit serum (20 minutes, 37 C). The sections were then incubated with the unconjugated lectin (Vector Laboratories, Burlingame, CA; 60 minutes, 37 C, for concentrations and sugar specificities see Table 1 ). After three washings in PBS, lectin incubation was followed by incubation with the respective goat-anti-lectin-antibody at a concentration of 5 hgl ml (Vector Laboratories, Burlingame, CA, 30 minutes, 37 C). Extensively washed slides were incubated with biotinylated rabbit-anti-goat-IgG (Zymed Laboratories, South San Francisco, CA, 10 minutes, 21 C) and subsequently (after three PBS washings) exposed to Streptavidin-Peroxidase (Zymed Laboratories, South San Francisco, CA; 1 :20 diluted, 5 minutes, 2 1 C). Visualization of the resulting immunocomplex was performed by incubation with 0.5 mglml 3,3'-diaminobenzidine tetrahydrochloride (Sigma Chemicals, St. Louis, MO) and 10 hl/ml 1% hydrogen peroxide in 0.05 M Tris-buffered 0.15 M saline (pH 7.6,4 minutes, 21 C). Either Gill's hematoxylin or methyl green was used for counterstaining.
Additionally, sections to be stained with Dolichos bijlorus agglutinin, Peanut agglutinin, Soybean agglutinin and Wheat germ agglutinin were treated with neuraminidase (type V, Sigma Chemicals, St. Louis, MO; 0.5 U/ml, 30 minutes, 37 C, pH 6.6) prior to incubation with the rabbit serum.
To determine the specificity of lectin binding, staining of negative controls was carried out by incubating serial sections of the hemangiomas and hemangiosarcomas with lectins that were preincubated with the appropriate inhibiting sugar (20 minutes, 0.2 M or 0.5 M; see Table 1 ). In each batch of slides, four serial sections from the same tumors were stained in this hapten inhibition test as negative controls.
Results
Lectin binding patterns for normal and neoplastic canine cutaneous endothelial cells are summarized in Table 2 . Normal canine endothelial cells seen in cutaneous blood vessels of varying sizes bound Grzfbnia sirnplicifolia-I (GS-I), Ricinus cornmunis agglutinin-I (RCA-I), Wheat germ agglutinin (WGA), and with less intensity Concanavalin A (Con A), Dolichos bzflorus agglutinin (DBA), and Soybean agglutinin (SBA). SBA ( Fig. 1 a-d ) bound only to small vessel endothelial cells and not to endothelial cells in larger arteries and veins. Peanut agglutinin (PNA) and Ulex europaeus agglutinin-I (UEA-I; Fig. 2a , b) did not bind to normal en- dothelial cells. Neuraminidase treatment of tissue sections resulted in an intensified SBA staining and a positive PNA reaction. Neuraminidase treatment did not alter DBA and WGA staining. WGA staining became relatively more prominent, however, due to reduced interstitial WGA staining after neuraminidase treatment. With the exception of Con A and SBA, in which binding intensities varied, lectin binding pattern was uniform, exhibiting no staining variation of vessels of different calibers and only minor variation between different tissue sections.
The morphology of hemangiomas was characterized by flattened endothelial cells lining the walls of bloodfilled caverns. A well-differentiated tumor stroma was present. In all hemangiomas, tumor cells uniformly stained for factor VIII related antigen (Fig. la) . All hemangiomas stained positively with GS-I (Fig. 3a, b ), RCA-I (Fig. 4a ), WGA (Fig. 4b) , as well as PNA (Fig.  5a, b) , SBA (Fig. Id) , and WGA after neuraminidase treatment. Compared to the uniform binding pattern of these lectins to normal endothelial cells, however, binding was rather heterogenous with positively and negatively staining cells within one tumor (Fig. 4a ) and a marked variation between different tumors. Direct comparison of staining intensity with adjacent normal cutaneous endothelial cells revealed a tendency towards increased WGA staining and reduction of staining intensity in GS-I and RCA-I. A reduction of staining intensity of neoplastic endothelial cells compared to normal endothelial cells was also present in neuraminidase pretreated sections stained with SBA and WGA. Con A, DBA, and DBA after neuraminidase treatment (Neu-DBA) bound weakly to endothelial cells in most hemangiomas. Five of ten hemangiomas expressed variable UEA-I binding not present in normal cutaneous endothelial cells (Fig. 2b) . In contrast to the binding of normal endothelial cells in small vessels, neoplastic canine endothelial cells did not bind SBA in untreated sections (Fig. lc) . PNA, which did not stain endothelial cells, selectively bound to the tumor stroma ( Fig. 5a ).
Hemangiosarcomas showed varying degrees of differentiation, ranging from islands of stroma lined by flattened or rounded endothelial cells to very undifferentiated pleomorphic cells in a rather solid configuration. All sarcomas tested positively for factor VIII related antigen, but staining was patchy. Solid undifferentiated tumor masses often did not express factor VIII related antigen. Lectin binding of hemangiosarcomas was similar to that of hemangiomas characterized by intense binding of GS-I, Con A, Neu-PNA, RCA-I, Neu-SBA, WGA, and Neu-WGA. While SBA did not bind to hemangiosarcomas, most tumors ex-hibited varying UEA-I binding. GS-I stained neoplastic cells in hemangiosarcomas rather selectively (Fig.  3b ), whereas the other lectins with varying intensities also bound to the tumor stroma and infiltrating inflammatory cells.
Staining of tissue sections with lectins that were preincubated with their respective sugars consistently stained negatively. It was not possible, however, to inhibit WGA binding by preincubation with N-acetylglucosamine, whereas preincubation with a mixture of 0.2 M neuraminic acid and 0.2 M N-acetylglucosamine resulted in complete inhibition of WGA binding.
Discussion
In this study, we compared the lectin binding pattern of neoplastic endothelial cells in canine hemangiomas and hemangiosarcomas with that of adjacent normal cutaneous endothelial cells. Since all tumors were pri- Skin, dog. Immunoperoxidase staining of Peanut agglutinin (PNA) binding sites in neoplastic endothelial cells. Methyl green counterstain (Fig. 5a ) Hemangiomas exhibit intense diffuse staining of the tumor stroma, while neoplastic endothelial cells do not bind PNA. (Fig. 5b ) After neuraminidase treatment, neoplastic endothelial cells intensely bind PNA. Staining of the tumor stroma is diminished. mary tumors and since the histopathologic diagnosis was confirmed in all tumors by the detection of factor VIII related antigen, this approach facilitated the direct comparison of neoplastic cells with their normal progenitor cells stained together on the same slide. The lectin binding pattern of normal canine cutaneous endothelial cells is similar to the binding pattern of endothelial cells in other organs and ~p e c i e s .~J~J~~'~ There are, however, some distinct differences within the literature data. Recently, a relatively constant lectin binding pattern of endothelial cells in ten different organs and ten different species with Grcfonia sirnplicifolia-I (GS-I), Ricinus cornmunis agglutinin-I (RCA-I), Wheat germ agglutinin (WGA), Soybean agglutinin after neuraminidase treatment (Neu-SBA), and Peanut agglutinin after neuraminidase treatment (Neu-PNA), and no binding of Concanavalin A (Con A), Dolichos bcj7orus agglutinin (DBA), and Soybean agglutinin (SBA) was reported.' Other authors describe organ specific,22 species specific, l o and age specificI8 differences in the lectin binding pattern of endothelial cells, as well as binding of Con A, DBA, and SBA by endothelial cells.6JoJ8,22 These differences most likely reflect the different techniques (cryostat sections versus paraffin sections, fluorescence techniques versus peroxidase techniques, direct methods versus indirect methods) that vary in sensitivity and overall ability to recognize lectin binding sites. For example, the intense binding of SBA and Con A to endothelial cells in hyperplastic human tonsils is strongly reduced in paraffin sections compared to cryostat sections. 28 In paraffin sections, they could only detect weak binding to endothelial cells in capillaries but not to endothelial cells in arteries and veins; furthermore, for structural biochemical conclusions on cell-surface glycosylation based on histochemical lectin binding experiments, it must be kept in mind that most lectins are defined by their monosaccharide specificity determined by a hapten inhibition test. For more and more lectins, however, it becomes evident that they a have a much higher affinity to oligosaccharides than to monosaccharides.15 This may explain why, in many studies, lectins with the same nominal monosaccharide specificity exhibit different histochemical binding patterns.
In this study, we used lectins for phenotypic probing of normal and neoplastic endothelial cells stained together on the same slide. This allowed the direct comparison of identically treated tissues. Direct comparison of normal and neoplastic canine endothelial cells revealed changes of staining intensities with some lectins. Despite the semiquantitative character of this study, a tendency towards reduced binding of GS-I, RCA-I, Neu-SBA, and WGA after neuraminidase treatment (Neu-WGA) was evident. SBA, which variably stained normal endothelial cells in small cutaneous vessels, did not bind to neoplastic endothelial cells. The loss of SBA binding reflects the absence of terminal N-acetylgalactosamine expression in hemangiomas and hemangiosarcomas and is most likely due to changes in the expression of differentiation markers during neoplastic transformation. WGA binding sites were expressed in higher quantity in neoplastic endothelial cells, and Ulex europaeus agglutinin-I (UEA-I), which recognizes L-fucose moieties, only bound to neoplastic cells in some tumors. Such an enhancement of glycoconjugate expression is not necessarily due to an elevated glycoconjugate biosynthesis,' but could also reflect the incomplete synthesis of carbohydrate chain^.^ Treatment of tissue sections with neuraminidase resulted only in a minor reduction of WGA binding to endothelial cells, suggesting either direct binding to terminal N-acetylglucosamine residues or binding to N-acetylglucosamine residues that were masked by sialic acid.
Similar quantitative changes in the glycoconjugate expression during neoplastic transformation have also been observed in other ~u~o~s ,~,~J~,~~,~~ but very few studies describe qualitative differences like the complete loss of SBA binding and the appearance of UEA-I binding seen in this study. Expression of UEA-I binding sites not present in the corresponding normal cells has also been observed in human colon adenocarcinoma cells and could be correlated with the degree of malignanc~.~.'~ The expression of UEA-I binding sites in malignant canine endothelial cells is of special interest, since UEA-I binding sites are expressed on normal human endothelial cells but not on most animal endothelial cells.'JO Due to the selective binding to endothelial cells, UEA-I is now accepted as a highly sensitive marker for vascular neoplasms in human
The expression of UEA-I binding sites in hemangiomas and hemangosarcomas clearly reflects the phenotypic alterations during tumorigenesis. It cannot be used, however, as a diagnostic marker for canine vascular tumors, since binding to tumor cells is heterogenous, not present in all tumors, and required a relatively high lectin concentration for detection compared to the other lectins used. Binding to normal endothelial cells was relatively uniform for all lectins used in this study. The binding of those same lectins varied strongly, however, for neoplastic endothelial cells. This shows the phenotypic heterogeneity of the tumorous endothelial cells. It also reflects the varying degrees of differentiation of neoplastic endothelial cells in different tumors as well as within one tumor.
Many authors have tried to use lectin histochemistry in order to find specific markers to aid in the diagnosis of certain tumors. With the exception of UEA-I as a marker for human vascular tumors, these approaches have proven largely unsuccessfu1. 4 The success of such studies is generally hindered by the fact that, in contrast to the selective expression of certain epitopes, carbohydrates are expressed rather ubiquitously. While this limits the use of lectins as a diagnostic instrument, lectin histochemistry can be used as a powerful research tool to compare the phenotypic properties of two cell populations. For example, as shown in this study, lectins can be used to analyze the phenotype of neoplastic cells in comparison to their progenitor cells, thus aiding the search for tumor cell surface characteristics that determine a specific antigenic phenotype.
